Showing results (221-230 of 252) with videos related to
Sort By:
Pageof 26
Pathologie-Biologie|October 14, 1998
[Multifocal tuberculosis. Apropos of 49 cases in the midwest region. GERICCO (Group for Epidemiology and Research in Clinical Infections of the Central West of France), 1991-1993]N Denis-Delpierre, D Merrien, E Billaud, et al.Presse Medicale (Paris, France : 1983)|October 13, 1998
[Extrapulmonary tuberculosis in the central western region. Retrospective study of 217 cases (Gericco 1991-1993)]N Denis-Delpierre, D Merrien, E Billaud, et al.Journal of Autoimmunity|September 22, 2018
Increased ischemic stroke, acute coronary artery disease and mortality in patients with granulomatosis with polyangiitis and microscopic polyangiitisM Mourguet, D Chauveau, S Faguer, et al.AIDS and Behavior|August 15, 2015
Prevalence and Risk Factors of Sleep Disturbance in a Large HIV-Infected Adult PopulationC Allavena, T Guimard, E Billaud, et al.Annales De Dermatologie Et De Venereologie|March 31, 2000
[Melanoma in organ transplant patients]L Lévêque, S Dalac, A Dompmartin, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|December 17, 2013
Cutaneous melanoma in patients treated with tumour necrosis factor inhibitors: a retrospective series of 15 patientsC Chabbert, H Adamski, G Guillet, et al.Medecine Et Maladies Infectieuses|September 6, 2005
[The Nadis cohort: 6236 HIV-infected patients followed up in French university hospitals]R Agher, C Duvivier, C Katlama, et al.La Revue De Medecine Interne|January 1, 1997
[Limitations of the protein profile for diagnostic orientation in initial internal medicine consultation. Prospective study on 76 patients]J H Barrier, M Herbouiller, D Le Carrer, et al.Annales De Dermatologie Et De Venereologie|August 3, 2025
Survival outcomes and response to immune checkpoint inhibitors among patients with advanced Merkel cell carcinoma: a retrospective study of 81 patientsC David, C Coquelle, Y Le Corre, et al.Medecine Et Maladies Infectieuses|December 26, 2018
Switching from abacavir/lamivudine plus nevirapine to abacavir/lamivudine/dolutegravir in virologically controlled HIV-infected adults (SWAD study)C Allavena, C Volteau, E André-Garnier, et al.Pageof 26